Crossmark

Development of NMR and thermal shift assays for the evaluation of<i>Mycobacterium tuberculosis</i>isocitrate lyase inhibitors

Crossref DOI link: https://doi.org/10.1039/c7md00456g

Published Online: 2017

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Bhusal, Ram Prasad https://orcid.org/0000-0002-2997-3995
Patel, Krunal https://orcid.org/0000-0001-9796-804X
Kwai, Brooke X. C. https://orcid.org/0000-0001-6378-9633
Swartjes, Anne https://orcid.org/0000-0002-3371-1920
Bashiri, Ghader https://orcid.org/0000-0002-5092-3749
Reynisson, Jóhannes https://orcid.org/0000-0003-4174-9512
Sperry, Jonathan https://orcid.org/0000-0001-7288-3939
Leung, Ivanhoe K. H. https://orcid.org/0000-0003-0633-6771
Funding

Funding for this research was provided by:

Health Research Council of New Zealand (Sir Charles Hercus Fellowship)

Maurice and Phyllis Paykel Trust (Grant-in-aid)
License Information

Version of Record valid from 2017-10-19
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Ram Prasad Bhusal (ORCID)

: Krunal Patel (ORCID)

: Brooke X. C. Kwai (ORCID)

: Anne Swartjes (ORCID)

: Anne Swartjes (ResearcherID)

: Ghader Bashiri (ORCID)

: Ghader Bashiri (ResearcherID)

: Jóhannes Reynisson (ORCID)

: Jonathan Sperry (ORCID)

: Ivanhoe K. H. Leung (ORCID)

: Ivanhoe K. H. Leung (ResearcherID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 5 September 2017; Accepted 16 October 2017; Accepted Manuscript published 17 October 2017; Advance Article published 6 November 2017; Version of Record published 16 November 2017